GE HealthCare Technologies
40 named things its latest annual report says its results depend on, each in the company's own words. 27 of them are also named by other companies we've read.
Customers
U.S. federal government spending reductions
earns fromnamed as a riskThese and similar spending reductions could result in contract terminations, delays, and cancellations of new procurements, and reductions in price and contract scope.Risk factors (Item 1A)
Suppliers
Contract manufacturing organizations
depends onnamed as a riskFor example, we rely on contract manufacturing organizations to produce certain of our molecular imaging pharmaceutical products.Risk factors (Item 1A)
Single-source and sole-source suppliers
depends onnamed as a riskFurther, we have multiple single-source or sole-source suppliers with no alternatives yet identified.Risk factors (Item 1A)
Also named by UCTT
Partners and platforms
GE Aerospace Trademark License Agreement
depends onnamed as a riskTermination of the Trademark License Agreement would eliminate our rights to use the specified trademarks granted to us under this agreement and may result in our having to negotiate a new or reinstated agreement with less favorable terms or cause us to lose our rights under the Trademark License Agreement, which would require us to change our corporate name and undergo significant rebranding efforts.Risk factors (Item 1A)
Other companies
Term Loan Facility
$500 million outstanding principalnamed as a riskAs of December 31, 2025, we have $9,500 million outstanding principal of fixed-rate senior unsecured notes and $500 million outstanding principal on the Term Loan Facility which carries a variable interest rate.Market risk (Item 7A)
Competitors
Independent service organizations (ISOs)
competes withnamed as a riskIncreased competition from ISOs and evolving regulatory and legislative policies could adversely impact our business and financial results.Risk factors (Item 1A)
Bayer
competes withIn our PDx business segment, we primarily compete with Bayer, Bracco, Guerbet, and Curium.Business (Item 1)
Siemens Healthineers
competes withIn the industries we serve, we believe our primary global competitors include Siemens Healthineers, Philips Healthcare, United Imaging, Mindray, and Canon, among others.Business (Item 1)
Also named by PROF
Philips Healthcare
competes withIn the industries we serve, we believe our primary global competitors include Siemens Healthineers, Philips Healthcare, United Imaging, Mindray, and Canon, among others.Business (Item 1)
United Imaging
competes withIn the industries we serve, we believe our primary global competitors include Siemens Healthineers, Philips Healthcare, United Imaging, Mindray, and Canon, among others.Business (Item 1)
Bracco
competes withIn our PDx business segment, we primarily compete with Bayer, Bracco, Guerbet, and Curium.Business (Item 1)
Places
China
operates innamed as a riskThe U.S., European Union (“EU”), and China are our most significant regions based on revenue and the regulatory landscape within these regions.Business (Item 1)
Also named by A, AA, AAOI, AAP, AAPL, AB, ADI, AEHR and 261 more
Russia
earns fromnamed as a riskThe implementation of these measures affected our ability to supply customers in Russia in 2025 and is expected to continue to do so as we confirm applicability of the U.S. License Exception to our transactions and continue to obtain licenses.Risk factors (Item 1A)
Also named by ALSN, ATR, AVY, AXP, BKR, BSX, C, CDNA and 50 more
India
depends onnamed as a riskSupply chain interruptions or price increases in certain key countries, such as China, India, Russia, and Israel, have had, and could continue to have, a similar adverse effect on our business.Risk factors (Item 1A)
Also named by A, AAPL, ACN, AJG, AKAM, AMZN, AOS, AVGO and 54 more
Israel
depends onnamed as a riskSupply chain interruptions or price increases in certain key countries, such as China, India, Russia, and Israel, have had, and could continue to have, a similar adverse effect on our business.Risk factors (Item 1A)
Also named by AIOT, AKAM, AMAT, AMGN, APP, ASTS, AVY, BSX and 31 more
Commodities and inputs
Euro
exposed to its pricenamed as a riskAs of the year ended December 31, 2025, our largest currency exposures are the Euro, Chinese Renminbi, Japanese Yen, Norwegian Krone, and British Pound Sterling.Risk factors (Item 1A)
Also named by ABBV, ABNB, ABT, ADBE, ADI, AME, AMG, AMGN and 186 more
Rare earth minerals
depends onnamed as a riskFor example, in 2025, China significantly tightened its export controls on rare earth minerals.Risk factors (Item 1A)
Also named by ALAB, AMAT, COHR, DE, EXTR, GE, GWW, JCI and 10 more
Helium
depends onnamed as a riskWe rely upon supplies of certain raw materials, including helium, iodine, and rare earth minerals.Risk factors (Item 1A)
Iodine
depends onnamed as a riskWe rely upon supplies of certain raw materials, including helium, iodine, and rare earth minerals.Risk factors (Item 1A)
Norwegian Krone
exposed to its pricenamed as a riskAs of the year ended December 31, 2025, our largest currency exposures are the Euro, Chinese Renminbi, Japanese Yen, Norwegian Krone, and British Pound Sterling.Risk factors (Item 1A)
Regulators
U.S. Food and Drug Administration (FDA)
subject tonamed as a riskThe FDA, the various competent authorities of the EU member states or other European countries that enforce the EU’s Medical Device Regulation, the EMA (for pharmaceuticals) in the EU, and the NMPA in China are the regulatory authorities affecting us most prominently with respect to the commercialization of our products, services, and solutions.Risk factors (Item 1A)
Also named by A, ABBV, ABT, AMGN, ARE, ARWR, ATR, AXGN and 112 more
Centers for Medicare and Medicaid Services (CMS)
subject tonamed as a riskDecision-making by our U.S. customers is complicated by the uncertainty surrounding Medicare reimbursement rates for certain procedures.Risk factors (Item 1A)
Also named by ABBV, CDNA, CHE, DGX, DOC, ENSG, GD, GHC and 6 more
European Medicines Agency (EMA)
subject tonamed as a riskThe FDA, the various competent authorities of the EU member states or other European countries that enforce the EU’s Medical Device Regulation, the EMA (for pharmaceuticals) in the EU, and the NMPA in China are the regulatory authorities affecting us most prominently with respect to the commercialization of our products, services, and solutions.Risk factors (Item 1A)
National Medical Products Administration (NMPA)
subject tonamed as a riskThe FDA, the various competent authorities of the EU member states or other European countries that enforce the EU’s Medical Device Regulation, the EMA (for pharmaceuticals) in the EU, and the NMPA in China are the regulatory authorities affecting us most prominently with respect to the commercialization of our products, services, and solutions.Risk factors (Item 1A)
Laws and programs
General Data Protection Regulation (GDPR)
subject to · up to 4% of a company’s global total annual revenuenamed as a riskMany of these laws impose a significant compliance burden on organizations within their scope, and failure to comply can result in a variety of sanctions, including, with respect to GDPR, administrative fines for the most serious compliance failures up to 4% of a company’s global total annual revenue of the preceding fiscal year.Business (Item 1)
Also named by A, AB, ABNB, ADBE, ADP, AGX, AIOT, AJG and 100 more
Medicare
earns fromnamed as a riskBecause the use of our products, services, and solutions is often reimbursed by the U.S. federal government through Medicare and Medicaid, we must comply with the AKS, the Sunshine Act, and the FCA.Risk factors (Item 1A)
Also named by ABT, ARWR, AXGN, BAX, BDX, BMY, BSX, CAH and 48 more
Foreign Corrupt Practices Act (FCPA)
subject tonamed as a riskThe failure to comply with the FCPA and similar anti-corruption and anti-bribery laws globally has resulted in, and could continue to result in, civil or criminal sanctions and adversely affect our business.Risk factors (Item 1A)
Also named by A, ADBE, ADP, AIR, AJG, ALB, AME, AMZN and 112 more
Medicaid
earns fromnamed as a riskBecause the use of our products, services, and solutions is often reimbursed by the U.S. federal government through Medicare and Medicaid, we must comply with the AKS, the Sunshine Act, and the FCA.Risk factors (Item 1A)
Also named by ABBV, ABT, ARE, ARWR, BAX, BMY, BSX, CHE and 39 more
HIPAA
subject tonamed as a riskAmong the most relevant and material of these regulations to our business, based on the volume and sensitivity of the data at issue, are: the U.S. Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information and Technology for Economic and Clinical Health Act (collectively “HIPAA”); the EU General Data Protection Regulation (Regulation (EU) 2016/679) (“GDPR”), similar United Kingdom (“U.K.”) legislation resulting from the European Union (Withdrawal) Data Act of 2018 (“U.K. GDPR”), and other EU country-level laws; the Lei Geral de Proteção de Dados Pessoias (“Brazil LGPD”); the various laws and accompanying regulations in China governing data privacy and cybersecurity (e.g., the Cybersecurity Law of the People’s Republic of China, Personal Information Protection Law (“China PIPL”) and Data Security Law (“China DSL”)), the Digital Personal Data Protection Act of India, and significant privacy legislation recently adopted in the Middle East and Africa Personal Data Protection Law (“PDPL”) Royal Decree No. M/19 on September 16, 2021.Business (Item 1)
Also named by AFL, BAX, BBSI, CI, DHR, DOC, DOCN, DOCU and 19 more
EU Medical Device Regulation
subject tonamed as a riskThe FDA, the various competent authorities of the EU member states or other European countries that enforce the EU’s Medical Device Regulation, the EMA (for pharmaceuticals) in the EU, and the NMPA in China are the regulatory authorities affecting us most prominently with respect to the commercialization of our products, services, and solutions.Risk factors (Item 1A)
Also named by ABBV, BAX, BDX, BSX, CAH, COO, DXCM, EW and 4 more
China volume-based procurement
subject tonamed as a riskFor example, China has implemented volume-based procurement processes to constrain healthcare costs.Risk factors (Item 1A)
Russia-Ukraine conflict sanctions
subject tonamed as a riskIn particular, the conflict between Ukraine and Russia and resulting sanctions and other restrictions imposed by the U.S., the EU, and Russia may negatively impact our business and financial results to the extent the conflict and the sanctions significantly impact our ability to sell products or services to customers in the affected countries, collect receivables from such customers, or repatriate cash we do collect.Risk factors (Item 1A)
China National Reimbursement Drug List
subject tonamed as a riskThe removal or reclassification of our products on Chinese national or provincial lists can affect the reimbursement or reimbursement rate of our products in China.Risk factors (Item 1A)
China healthcare anti-corruption campaign
subject tonamed as a riskIn 2023, China’s Central Commission for Discipline Inspection, the National Supervisory Commission, and other governmental entities in China initiated an anti-corruption campaign focused on the healthcare sector, which contributed to delayed orders and sales in our China business.Risk factors (Item 1A)
Also named by ISRG
U.S.-China bilateral tariffs
subject tonamed as a riskWhile the situation continues to be fluid, tariffs materially impacted our profitability and cash flows in 2025, primarily the bilateral U.S. and Chinese tariffs and U.S. tariffs on all other global import suppliers.Risk factors (Item 1A)
China two-invoice policy
subject tonamed as a riskThe continued existence, and any expansion and tightening, of this policy could present significant challenges for our relevant products to reach a larger geographic area in China.Risk factors (Item 1A)
China localization requirements
subject tonamed as a riskThe implementation of localization requirements and the other government policies in certain geographies such as China and Russia creates a risk that, if we do not localize our products or operations to meet such requirements, we could lose market share and experience adverse effects on our business results, cash flows, and financial condition.Risk factors (Item 1A)
GE Aerospace Tax Matters Agreement
named as a riskIf, as a result of any of our representations being untrue or our covenants being breached, the Spin-Off were determined not to qualify for non-recognition of gain or loss under Section 355 and related provisions of the Code, we could be required by our Tax Matters Agreement with GE to indemnify GE for the resulting taxes and related expenses.Risk factors (Item 1A)
U.S. copyright act exemption for medical device repair
subject tonamed as a riskSpecifically, the Librarian of Congress in the U.S. has authorized a copyright act exemption that allows third-party repair companies to circumvent OEM copyright protections on software in its medical imaging device or system if circumvention is necessary to diagnose, maintain, or repair such device or system.Risk factors (Item 1A)